Valeant CEO says he, company were 'too aggressive' in boosting drug prices

Valeant Pharmaceutical's soon-to-be-former CEO, J. Michael Pearson, is to tell U.S. Senate committee that he and the company were 'too aggressive' in bumping up prices on some of its drug products.

from CBC | Health News http://ift.tt/1NTBtmV